Business
Psychedelic biotech Psylo raises first funds – The Australian Financial Review
Startmate company Psylo is the latest company to attract funding for its pre-clinical psychedelic research.
The space is also attracting big investment dollars in the US, UK and Europe, with Beckley Psytech raising $US80 million in August, Atai Life Sciences raising $225 million for a NASDAQ listing in 2020 and new Chicago-based venture capital group Palo Santo…
Continue Reading
-
Business20 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
Noosa News15 hours agoRacing Queensland responds to criticism of ‘deadliest’ greyhound track
-
Noosa News23 hours agoDramatic details emerge of moment woman loses arm in attack by lion in Queensland Zoo
-
General19 hours agoTrump’s AUKUS review coming soon. Will he stop the folly?